Answers are grounded in this paper and cite their sources.
Purpose Resuscitation strategies incorporating peripheral perfusion targets (RSIPPT) have emerged as promising tools in septic shock. However, whether they improve clinically relevant outcomes remains uncertain. We aimed to evaluate whether these strategies reduce 28/30-day mortality and improve other clinical outcomes compared with usual care. Methods A systematic review and meta-analysis of randomized controlled trials (RCTs) using a random-effects model was conducted. Electronic searches of PubMed, EMBASE, and CENTRAL were performed through May 27, 2026 (PROSPERO CRD420261400115). The RoB 2 and GRADE tools were used for assessment of risk of bias and certainty of evidence (CoE), respectively. Results Five RCTs involving 2180 patients with septic shock were included. Compared with conventional strategies, RSIPPT were not associated with significant differences in 28/30-day mortality (four RCTs; RR 0.92, 95% CI 0.78–1.09; I 2 = 10%; moderate CoE) or 90-day mortality (three RCTs; RR 0.94, 95% CI 0.83–1.05; I 2 = 0%; low CoE). However, RSIPPT were associated with fluid reduction during the first 6–8 h of resuscitation (three RCTs; MD −264.53 mL, 95% CI −425.28 to −103.77; I 2 = 1%; low CoE). No significant differences were observed in intensive care unit or hospital length of stay, organ dysfunction, vasopressor-free days, ventilator-free days, or renal replacement therapy-free days. Conclusion In early septic shock, RSIPPT were associated with a modest reduction in resuscitation fluid during the first 6–8 h. A mortality reduction was not demonstrated, although clinically important benefit or harm cannot be excluded. Differences in intervention algorithms and comparators limit attribution of these findings to peripheral perfusion monitoring itself.
No takes yet. Share an insight, caveat, or question.
Bispo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: